Retrospective study on the clinical effect of 'mediating Sanjiao' in treating chronic kidney disease
- Conditions
- CKD
- Registration Number
- ITMCTR2100004221
- Lead Sponsor
- onghua Hospital Affiliated to Shanghai University of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients meeting the diagnostic criteria of chronic kidney disease: renal injury or GFR < 60ml / min / 1.73m2, lasting for 3 months; renal injury includes: abnormal renal pathology or abnormal blood, urine and imaging examination; ckd1-5 is not limited, and renal replacement therapy has not been performed before the start of traditional Chinese Medicine treatment; 2;
2. Patients with TCM syndrome diagnostic criteria: according to the clinical manifestations of patients, they belong to asthenia disease and edema disease, referring to the guiding principles for clinical research of new drugs of traditional Chinese medicine (Trial Implementation) in 2002;
3. The patients who had been treated with mediating Sanjiao for more than 6 months and had complete clinical efficacy and safety indexes before and after treatment;
4. Age, gender and nationality are not limited.
1. Those patients who took Chinese medicine irregularly and took less than 126 days in 6 months (< 70%);
2. The patients who take traditional Chinese medicine do not belong to the mediation Sanjiao kidney treatment series;
3. Patients who do not agree or refuse to provide clinical data after knowing.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scr;
- Secondary Outcome Measures
Name Time Method